Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan

For decades, psychostimulants have been the gold standard pharmaceutical treatment for attention-deficit/hyperactivity disorder (ADHD). In the United States, an astounding 9% of all boys and 4% of girls will be prescribed stimulant drugs at some point during their childhood. Recent meta-analyses hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Cintya Nirvana, Christov-Moore, Leonardo, Ombao, Hernando, Douglas, Pamela K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Human Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548548/
https://www.ncbi.nlm.nih.gov/pubmed/36226261
http://dx.doi.org/10.3389/fnhum.2022.938501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548548/
https://www.ncbi.nlm.nih.gov/pubmed/36226261
http://dx.doi.org/10.3389/fnhum.2022.938501

Ejemplares similares